Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.
- DOI
- 10.1016/j.ebiom.2026.106532
- Published
- 2026 Oct 27
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2026.106532,
title = {Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.},
author = {Biral LPA and Russell V and Selim MA and Roth C and Love C and Shingleton J and Owusu D and Batra A and Mason EF and Kovach A and Amador C and Koff JL and Jaye D and Cheng CL and Evans A and Pillai R and Leppä S and Hsi ED and Ondrejka S and McKinney M and McCall CM and Bettoney S and Sojitra P and Evens A and Behdad A and Galvez C and Fedoriw Y and Thacker E and Thakkar D and Parker C and Happ L and Czader M and Gulati R and Naresh KN and Dave SS and Wang J},
year = {2026},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2026.106532},
url = {https://doi.org/10.1016/j.ebiom.2026.106532}
}RIS
TY - JOUR TI - Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study. AU - Biral LPA AU - Russell V AU - Selim MA AU - Roth C AU - Love C AU - Shingleton J AU - Owusu D AU - Batra A AU - Mason EF AU - Kovach A AU - Amador C AU - Koff JL AU - Jaye D AU - Cheng CL AU - Evans A AU - Pillai R AU - Leppä S AU - Hsi ED AU - Ondrejka S AU - McKinney M AU - McCall CM AU - Bettoney S AU - Sojitra P AU - Evens A AU - Behdad A AU - Galvez C AU - Fedoriw Y AU - Thacker E AU - Thakkar D AU - Parker C AU - Happ L AU - Czader M AU - Gulati R AU - Naresh KN AU - Dave SS AU - Wang J PY - 2026 JO - EBioMedicine DO - 10.1016/j.ebiom.2026.106532 UR - https://doi.org/10.1016/j.ebiom.2026.106532 ER -
APA
LPA, B., V, R., MA, S., C, R., C, L., J, S., D, O., A, B., EF, M., A, K., C, A., JL, K., D, J., CL, C., A, E., R, P., S, L., ED, H., S, O., M, M., CM, M., S, B., P, S., A, E., A, B., C, G., Y, F., E, T., D, T., C, P., L, H., M, C., R, G., KN, N., SS, D., & J, W. (2026). Characterising the genomic landscape of two clinical risk groups in CD30+ T-cell lymphoproliferative disorders with cutaneous involvement: a multi-institutional retrospective study.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2026.106532
Source records
- pubmed · retrieved 2026-11-10T12:23:12.210Z